Schizophrenia is a brain disorder with a lifetime prevalence near 1% that is associated with high levels of functional impairment and low expectations for recovery.1 Only 10% to 15% of people with schizophrenia work. The annual cost of schizophrenia in the United States in 2013 was estimated to be approximately $155.7 billion, including significant direct and indirect costs.2 Delivery of a new treatment approach called coordinated specialty care (CSC) to every young person experiencing the psychosis of early schizophrenia could change this state of affairs. The critical question is, “what will it take to make this happen?”
Dixon L. What It Will Take to Make Coordinated Specialty Care Available to Anyone Experiencing Early Schizophrenia: Getting Over the Hump. JAMA Psychiatry. 2017;74(1):7–8. doi:10.1001/jamapsychiatry.2016.2665
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.